thymosin alpha 1 for use in the treatment of cystic fibrosis

• 收藏
• 分享

专利权人:

ENRICO GARACI;LUIGINA ROMANI

发明人:

ENRICO GARACI,LUIGINA ROMANI

申请号：

BR112017016205

公开号：

BR112017016205A2

申请日:

2016.02.04

申请国别(地区):

BR

年份:

2018

代理人:

摘要：

The present invention relates to thymosin alpha 1 (ta1) for use in the treatment of cystic fibrosis as an rtfc correcting agent, rtfc enhancer and anti-inflammatory.a presente invenção refere-se à thymosin alpha 1 (ta1) para uso no tratamento de fibrose cística, como um agente corretor de rtfc, potencializador de rtfc e anti-inflamatório.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/